Skip to content

Modified Alliance-Focused Training with Doubling (MAFT-D) as an integrative approach to improve therapists’ competencies in dealing with alliance ruptures and prevent negative outcome in psychotherapy for depression. A randomized controlled multicenter trial.

Modified Alliance-Focused Training with Doubling (MAFT-D) as an integrative approach to improve therapists’ competencies in dealing with alliance ruptures and prevent negative outcome in psychotherapy for depression. A randomized controlled multicenter trial. - RCT MAFT-D

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
DRKS
Registry ID
DRKS00014842
Enrollment
248
Registered
2018-07-10
Start date
2024-07-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive and related disorders (DSM-V): major depressive disorder (single episode, recurrent), persistent depressive disorder, other specified depressive disorders F32 F33 F34.1

Interventions

Group 1: Therapists randomized to MAFT-D will receive a two-day workshop (theoretical introduction and role plays based on individual case examples) followed by group supervision carried out by superv
B) Introduction of the patient and characteristics of the therapeutic relationship
C) First role-play and “doubling” (psychodrama technique)
D) Second role-play and “doubling”
E) Third role-play and own contributions (Supervisor asks whether own biographical issues may have been ‘triggered’). Supervisors belonging to MAFT-D will receive a two-day workshop before start of st

Sponsors

Professur für Psychosomatik und Psychotherapie, Psychologische Hochschule Berlin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Outpatients, Cognitive-behavioral (CBT) or Psychodynamic (PDT) therapy, once-weekly 50min sessions; both sexes; = 18 yrs.; primary DSM-V diagnosis of depressive and related disorders; BDI-II score = 20

Exclusion criteria

Exclusion criteria: Current/past diagnosis of psychotic disorder or dementia; substance dependency disorder (current/during the last 12 months); acute suicidal plans or attempts within the last 6 months; psychopharmacotherapy other than antidepressants or change of antidepressant regimen during the last month or planned for the next months; planned concurrent psychological treatments (e.g.; inpatient/day-care treatment; outpatient treatments > 4 sessions); insufficient command of the German language

Design outcomes

Primary

MeasureTime frame
a) change in patient-rated depressive symptoms (first primary endpoint) measured using the BDI-II (difference from baseline to 20 weeks after randomization), b) premature therapy dropout (second primary endpoint), patient interviews

Secondary

MeasureTime frame
- change in patient-rated depressive symptoms (BDI-II) (difference from baseline to 35 weeks, 20 months, 36 months after randomization) - dropout at 35 weeks, 20 months, 36 months - change in observer-rated depressive symptoms (difference from baseline to 20, 35 weeks, 20, 36 months after randomization) (GRID-HAM-D) - change in patient-rated anxiety (difference from baseline to 20, 35 weeks, 20, 36 months after randomization (GAD-7) - change in patient-rated somatic symptoms (difference from baseline to 20, 35 weeks, 20, 36 months after randomization) (PHQ-15) - change in patient-rated personality structure deficits (difference from baseline to 20, 35 weeks, 20, 36 months after randomization) (OPD-SQS) - change in patient-rated interpersonal problems (difference from baseline to 20, 35 weeks, 20, 36 months after randomization) (IIP-32) - change in patient-rated quality of life (difference from baseline to 20, 35 weeks, 20, 36 months after randomization) (WHOQOL–BREF) - change in observer-rated therapeutic competence (interpersonal skills) (difference from baseline to week 35 after randomization of the first patient) (Facilitative Interpersonal Skills Performance Test, FIS) - change in therapist-rated trait-like relational manner in therapy and change in therapist-rated therapeutic competence (difference from baseline to 20 weeks, 35 weeks, 20 months, 36 months after randomization of the first patient) (trait section and skills change index section of the Adapted Trainee Current Practice Report. - therapist-rated retrospective satisfaction with supervision at week 20, 35 and months 20 and 36 after randomization of the first patient (CSQ-8) - change in therapist-rated emotional suppression (difference from baseline to 20 weeks, 35 weeks, 20 months, 36 months after randomization of the first patient) (ERQ) - change in alexithymia (difference from baseline to 20 weeks, 35 weeks, 20 months, 36 months after randomization of the first patient) (TAS-26)

Countries

Germany

Contacts

Public ContactAntje Gumz

Psychologische Hochschule Berlin

a.gumz@phb.de00491635026408

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026